Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
32,385,258
-
Share change
-
+1,187,685
-
Total reported value
-
$71,560,621
-
Put/Call ratio
-
232%
-
Price per share
-
$2.21
-
Number of holders
-
109
-
Value change
-
+$3,233,086
-
Number of buys
-
47
-
Number of sells
-
55
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q4 2025
As of 31 Dec 2025,
Pulmonx Corp - COM (LUNG) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,385,258 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, MORGAN STANLEY, BlackRock, Inc., VANGUARD GROUP INC, Soleus Capital Management, L.P., ExodusPoint Capital Management, LP, SILVERCREST ASSET MANAGEMENT GROUP LLC, DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.